Leave a request
Siemens Healthineers announced the company's Atellica VTLi Patient-Side Immunoassay Analyzer2 has obtained CE mark and is expected to be available later this spring. The Atellica VTLi analyzer provides lab standard, high-sensitivity cardiac troponin I (hs-cTnI) test results to clinicians in eight minutes using a patient's fingerstick blood sample.
With this industry first technology, Siemens Healthineers is helping to improve the patient care paradigm with its disruptive technology, providing hs-cTnI results at the patient’s side to help clinicians properly diagnose and treat heart attacks with confidence.
Responsible for an estimated 31 percent of all deaths worldwide, cardiovascular disease is the leading cause of death.3 Fast triage for patients presenting with symptoms can help save lives.
The substantial reduction in turnaround time achieved when introducing the wireless, handheld Atellica VTLi analyzer may offer clinicians a fast pathway to help diagnose and treat their patients, helping to accelerate care, improve patient outcomes, and reduce the strain felt in overcrowded EDs.
The Atellica VTLi system has wireless capability that easily integrates and directly connects to data management systems, including the Siemens Healthineers POC Ecosystem Solution, and the laboratory and hospital information systems. Together, this offering provides the laboratory centralized control over decentralized point-of-care testing.
By Аvera Allen | Linkedin
#News #Health #Medical #Atellica #Siemens #Whealthnews
Leave a request